A. Vega

发表

Model for Early Detection of Breast Cancer in Low-Resource Areas: The Experience in Peru

V. Tsu, J. Jeronimo, C. Bain, 2018, Journal of global oncology.

Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru

B. Anderson, J. Zunt, Kay M. Johnson, 2017, JAMA oncology.

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

J. Chang-Claude, D. Soria, P. Seibold, 2022, Advances in radiation oncology.

Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.

R. Steenbakkers, J. Dennis, A. Crijns, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, EBioMedicine.

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

J. Chang-Claude, K. Haustermans, P. Seibold, 2022, Frontiers in Oncology.

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis

A. Dunning, C. Luccarini, B. Alizadeh, 2022, British Journal of Cancer.

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer.

Tim E. Ward, J. Chang-Claude, E. Messing, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors

J. Chang-Claude, P. Seibold, D. Ruysscher, 2019, International Journal of Radiation Oncology*Biology*Physics.

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.

J. Chang-Claude, C. Luccarini, P. Seibold, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).

Tim E. Ward, J. Chang-Claude, A. Dunning, 2022, Lung Cancer.

Cancer Management and Research Dovepress Egfr Testing and Clinical Management of Advanced Nsclc: a Galician Lung Cancer Group Study (ggcp 048-10)

I. Abdulkader, L. Santomé, M. Lázaro, 2022 .

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Tim E. Ward, J. Chang-Claude, P. Seibold, 2023, International journal of cancer.

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Maria Carmen De Santis, P. Seibold, D. Ruysscher, 2023, Breast.

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

P. Seibold, D. de Ruysscher, S. Gutiérrez‐Enríquez, 2023, Acta oncologica.

The REQUITE Project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

P. Lambin, D. Ruysscher, S. Gutiérrez‐Enríquez, 2016 .

OC-0647 Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project

P. Lambin, J. Chang-Claude, P. Seibold, 2019, Radiotherapy and Oncology.